The raised guidance and strong organic growth (18% ex-Copra) signal sustained brand momentum, but the Q4 gross margin warning (~33%) and heavy cash deployment for Copra ($139M) warrant monitoring of margin recovery and integration execution in early 2027.
Price Chart
Executive Summary
Vita Coco reported Q3 2026 net sales of $244M (+34% YoY) and diluted EPS of $0.58, beating the $0.53 consensus. The company raised full-year 2026 guidance for net sales to $810M-$820M (from $790M-$805M) and Adjusted EBITDA to $170M-$175M (from $154M-$161M), driven by strong branded retail growth and the Copra acquisition. Organic net sales growth (ex-Copra) was 18%, and operating cash flow for nine months reached $152M, up from $51M a year ago.
Key Financial Metrics
Key Facts
- Q3 2026 net sales $243.8M, up 34% YoY from $182.3M
- Diluted EPS $0.58 vs $0.40 YoY; consensus was $0.53 — beat of ~9.4%
- Organic net sales growth (ex-Copra) 17.8% in Q3
- Vita Coco Coconut Water net sales grew 15% in Q3; Private Label grew 152% (includes Copra)
- Gross margin 38.0% in Q3, consistent with 37.7% a year ago
- Adjusted EBITDA $53.2M in Q3 vs $32.4M YoY, up 64%
- Full-year 2026 guidance raised: net sales $810M-$820M, Adjusted EBITDA $170M-$175M
- Q4 2026 gross margin expected ~33% due to cost increases and no offsetting price actions until early 2027
- Cash and equivalents $152M, no debt; $139M net cash used for Copra acquisition
- Year-to-date share repurchases $62M; $11M remaining under $105M authorization
Financial Impact
Q3 revenue beat consensus by ~$13.7M (6%); EPS beat by $0.05 (9.4%); guidance raised by $20M at midpoint for revenue and $15M for EBITDA
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Americas | $198.6M | +30.9% |
| International | $45.3M | +48.0% |
Risk Factors
- Q4 2026 gross margin expected to drop to ~33% from 38% in Q3 due to cost pressures and no price actions until early 2027
- Cash balance declined $127M from Q2 end due to Copra acquisition; $152M remaining
- Copra acquisition adds execution risk and contingent earn-out liability of $55.1M
- Tariff and geopolitical uncertainty (Iran conflict) cited as risk factors
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001482981-26-000183 |
| Document: coco-20261022.htm | 0001482981-26-000183 |
| Document: 0001482981-26-000183-index-headers.html | 0001482981-26-000183 |
| Document: 0001482981-26-000183-index.html | 0001482981-26-000183 |
| Document: 0001482981-26-000183.txt | 0001482981-26-000183 |
| 8-K Data (Synthetic) | 0001482981-26-000183 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | Press Release | $56.53 | awaiting T+5 | — | $55.79 (−1.30%) |
Oct 22, 2026 4d ago | 8-K | $59.00 | awaiting T+5 | — | $55.79 (−5.43%) |
Oct 22, 2026 4d ago | Press Release | $59.00 | awaiting T+5 | — | $55.79 (−5.43%) |
Jul 23, 2026 13w ago | 8-K | $69.37 $66.95 | ▼ −3.49% | ▼ −3.96% | $55.79 (−19.57%) |
Jun 15, 2026 19w ago | Insider Cluster | $83.87 $82.74 | ▼ −1.35% | ▲ +0.89% | $55.79 (−33.47%) |
May 8, 2026 24w ago | Insider Cluster | $71.60 $76.44 | ▲ +6.76% | ▲ +5.30% | $55.79 (−22.07%) |
May 5, 2026 24w ago | Press Release | $67.79 $72.46 | ▲ +6.89% | ▲ +4.90% | $55.79 (−17.69%) |
Apr 29, 2026 25w ago | 144 | $66.95 $67.79 | ▼ −1.25% | ▲ +1.86% | $55.79 (+16.66%) |
Apr 29, 2026 25w ago | 8-K | $66.95 $67.79 | ▲ +1.25% | ▼ −1.86% | $55.79 (−16.66%) |
Apr 29, 2026 25w ago | Insider Cluster | $66.95 $67.79 | ▼ −1.25% | ▲ +1.86% | $55.79 (+16.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers